Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Oct 22;22(4):710–716. doi: 10.1016/j.bbmt.2015.10.009

Table.

Patient, Transplant and BOS characteristics (N=36)

Characteristic

Age, median years (range) 57 (24–72)

Sex, n
 Male 19
 Female 17

Race/ethnicity, n
 Caucasian, non-Hispanic 33
 Caucasian, Hispanic 1
 African American 2
 Unknown 1

Disease, n
 Acute leukemia 13
 Myelodysplastic syndrome 5
 Chronic leukemia 7
 Lymphoma 4
 Other 7

Time from transplant to BOS diagnosis, median year (range) 1.5 (0.4–11.0)

Enrollment FEV1% predicted, median (range) 46% (21%–75%)

FEV1/VC, median (range) 0.5 (0.28–0.75)

Abbreviations: BOS, bronchiolitis obliterans syndrome; FEV1, forced expiratory volume-first second; VC, vital capacity

HHS Vulnerability Disclosure